ICU Medical, Inc.
ICUI
$148.44
-$0.70-0.47%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 536.99M | 548.87M | 604.70M | 629.81M | 589.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 536.99M | 548.87M | 604.70M | 629.81M | 589.13M |
| Cost of Revenue | 336.11M | 340.80M | 394.59M | 402.55M | 384.28M |
| Gross Profit | 200.88M | 208.06M | 210.11M | 227.26M | 204.85M |
| SG&A Expenses | 152.77M | 159.39M | 157.23M | 158.85M | 162.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 510.13M | 522.06M | 575.12M | 583.75M | 568.01M |
| Operating Income | 26.86M | 26.81M | 29.59M | 46.05M | 21.12M |
| Income Before Tax | -4.05M | 36.52M | -10.91M | 8.22M | -17.93M |
| Income Tax Expenses | -658.00K | 1.18M | 4.57M | 32.05M | 15.06M |
| Earnings from Continuing Operations | -3.40M | 35.34M | -15.48M | -23.83M | -32.98M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.40M | 35.34M | -15.48M | -23.83M | -32.98M |
| EBIT | 26.86M | 26.81M | 29.59M | 46.05M | 21.12M |
| EBITDA | 77.66M | 76.47M | 79.03M | 99.05M | 76.79M |
| EPS Basic | -0.14 | 1.43 | -0.63 | -0.97 | -1.35 |
| Normalized Basic EPS | 0.19 | 0.28 | 0.15 | 0.38 | -0.13 |
| EPS Diluted | -0.14 | 1.43 | -0.63 | -0.98 | -1.35 |
| Normalized Diluted EPS | 0.19 | 0.28 | 0.15 | 0.38 | -0.13 |
| Average Basic Shares Outstanding | 24.69M | 24.65M | 24.54M | 24.49M | 24.44M |
| Average Diluted Shares Outstanding | 24.69M | 24.71M | 24.54M | 24.49M | 24.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |